Combination Oral Chelation in Adult Patients With Transfusion-dependent Thalassemia and High Iron Burden

被引：9

作者：

Hammond, John ^{[1
]}

Thompson, Alexis A. ^{[4
,5
]}

Fogel, Mark A. ^{[2
]}

Hammond, Katherine ^{[4
]}

Kokroko, Jolene ^{[1
]}

Kwiatkowski, Janet L. ^{[1
,3
]}

机构：

[1] Childrens Hosp Philadelphia, Div Hematol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA

[2] Childrens Hosp Philadelphia, Div Cardiol, 34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA

[3] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA

[4] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol, Chicago, IL 60611 USA

[5] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2019年 / 41卷 / 01期

关键词：

thalassemia; iron overload; deferasirox; deferiprone; MYOCARDIAL IRON; DEFERIPRONE THERAPY; DEFERASIROX; SAFETY; DEFEROXAMINE; TRIAL; RISK;

D O I：

10.1097/MPH.0000000000001269

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

An open-label, pilot study was conducted to evaluate deferasirox/deferiprone combination chelation therapy in adult patients with transfusion-dependent thalassemia and severe iron overload. Enrollment proved difficult. Nine patients (median age, 27.4 y; ferritin, 4965 ng/mL; liver iron concentration, 28.5 mg/g dry weight; cardiac T2*, 13.3 ms) received treatment. Two were withdrawn for treatment-related adverse effects. Arthralgia (4 patients) and gastrointestinal symptoms (5 patients) were common; no episodes of neutropenia/agranulocytosis occurred. Adherence difficulties were common. Of 6 patients with 12 to 18 months follow-up, 3 showed improvement in cardiac T2* and 2 in liver iron. Combination oral chelation may be effective but adverse effects and adherence challenges may limit efficacy.

引用

页码：E47 / E50

页数：4

共 50 条

[41] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia [J].

Angelopoulos, NG ;

Goula, A ;

Rombopoulos, G ;

Kaltzidou, V ;

Katounda, E ;

Kaltsas, D ;

Tolis, G .

JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (02) :138-145

[42] Endocrinopathies in patients with transfusion-dependent ß-thalassemia [J].

Mehrvar, A. ;

Azarkeivan, A. ;

Faranoush, M. ;

Mehrvar, N. ;

Saberinedjad, J. ;

Ghorbani, R. ;

Vossough, P. .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2008, 25 (03) :187-194

[43] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia [J].

Nicholas G. Angelopoulos ;

Anastasia Goula ;

Grigorios Rombopoulos ;

Victoria Kaltzidou ;

Eugenia Katounda ;

Dimitrios Kaltsas ;

George Tolis .

Journal of Bone and Mineral Metabolism, 2006, 24 :138-145

[44] Efficacy and Safety of Combined Oral Chelation with Deferiprone and Deferasirox on Iron Overload in Transfusion Dependent Children with Thalassemia - A Prospective Observational Study [J].

DivakarJose, Rajeswari Rethinaswamy ;

Delhikumar, C. G. ;

Kumar, G. Ram .

INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (04) :330-335

[45] Efficacy and Safety of Combined Oral Chelation with Deferiprone and Deferasirox on Iron Overload in Transfusion Dependent Children with Thalassemia – A Prospective Observational Study [J].

Rajeswari Rethinaswamy DivakarJose ;

C. G. Delhikumar ;

G. Ram Kumar .

Indian Journal of Pediatrics, 2021, 88 :330-335

[46] Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias [J].

Kate Hanneman ;

Vikram M. Raju ;

Hadas Moshonov ;

Richard Ward ;

Bernd J. Wintersperger ;

Andrew M. Crean ;

Heather Ross ;

Elsie T. Nguyen .

The International Journal of Cardiovascular Imaging, 2013, 29 :1517-1526

[47] Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial [J].

Premawardhena, Anuja ;

Wanasinghe, Sakuni ;

Perera, Chamodi ;

Wijethilaka, Muditha Nayana ;

Rajakaruna, R. H. M. G. ;

Samarasinghe, R. A. N. K. K. ;

Williams, Senani ;

Mettananda, Sachith .

LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 30

[48] Iron overload in transfusion-dependent patients [J].

Coates, Thomas D. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, :337-344

[49] MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox [J].

Antonella Meloni ;

Mari Giovanna Neri ;

Maria Chiara Resta ;

Massimiliano Missere ;

Antonino Vallone ;

Vincenzo Positano ;

Silvia Macchi ;

Crocetta Argento ;

Daniele De Marchi ;

Alessia Pepe .

Journal of Cardiovascular Magnetic Resonance, 17 (Suppl 1)

[50] Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience [J].

Karakas, Zeynep ;

Yilmaz, Yasin ;

Bayramoglu, Zuhal ;

Karaman, Serap ;

Aydogdu, Selime ;

Karagenc, Ayse Ozkan ;

Tugcu, Deniz ;

Dursun, Memduh .

RADIOLOGIA MEDICA, 2018, 123 (08) :572-576

← 1 2 3 4 5 →